Institute for Wealth Management’s West Pharmaceutical WST Stock Holding History

Institute for Wealth Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6K	Buy	+35	New	+$10.7K	﹤0.01%	1266

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Institute for Wealth Management's WST Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 35 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #1266 among its holdings.

464 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Institute for Wealth Management held 35 shares of West Pharmaceutical worth $12.6K as of Q2 2026.
West Pharmaceutical was a new Institute for Wealth Management position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1266 holding.
464 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.